Incorporation of HPV-DNA molecular test into the Brazilian healthcare system

Key Points

• The incorporation of the HPV-DNA molecular test improves early detection of cervical cancer, enhancing patient outcomes.
• Evidence suggests that implementing this test leads to more accurate screening compared to traditional methods in Brazil.
• Analysis of healthcare records shows that regions adopting the molecular test see a significant increase in cervical cancer screenings.
• Highlights the potential to integrate innovative molecular approaches in public health systems, calling for broader implementation.